ATE401860T1 - Volumensparende arzneiform zur kontrollierten freisetzung - Google Patents

Volumensparende arzneiform zur kontrollierten freisetzung

Info

Publication number
ATE401860T1
ATE401860T1 AT03721484T AT03721484T ATE401860T1 AT E401860 T1 ATE401860 T1 AT E401860T1 AT 03721484 T AT03721484 T AT 03721484T AT 03721484 T AT03721484 T AT 03721484T AT E401860 T1 ATE401860 T1 AT E401860T1
Authority
AT
Austria
Prior art keywords
active agent
layer
controlled release
membrane system
dosage form
Prior art date
Application number
AT03721484T
Other languages
English (en)
Inventor
Patrick Wong
Francisco Jao
David Edgren
Robert Skluzacek
Shu Li
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE401860T1 publication Critical patent/ATE401860T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03721484T 2002-03-29 2003-03-28 Volumensparende arzneiform zur kontrollierten freisetzung ATE401860T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36871402P 2002-03-29 2002-03-29
US40406102P 2002-08-16 2002-08-16

Publications (1)

Publication Number Publication Date
ATE401860T1 true ATE401860T1 (de) 2008-08-15

Family

ID=28678251

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03721484T ATE401860T1 (de) 2002-03-29 2003-03-28 Volumensparende arzneiform zur kontrollierten freisetzung

Country Status (8)

Country Link
US (2) US20030185888A1 (de)
EP (1) EP1499289B1 (de)
JP (1) JP2005521706A (de)
AT (1) ATE401860T1 (de)
AU (1) AU2003224794A1 (de)
CA (1) CA2481236A1 (de)
DE (1) DE60322371D1 (de)
WO (1) WO2003082207A2 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203296D0 (en) 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
AR039744A1 (es) * 2002-06-26 2005-03-09 Alza Corp Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
CA2564227A1 (en) * 2003-09-02 2005-03-10 Alza Corporation Novel drug compositions and dosage forms of topiramate
CA2545834A1 (en) * 2003-11-14 2005-06-02 Alza Corporation Controlled release of topiramate in liquid dosage forms
CN1997372B (zh) * 2004-06-24 2010-06-02 西梯茜生命工学股份有限公司 包含依他康那唑的固态分散剂的制造方法及其医药组成物
WO2006007354A2 (en) * 2004-06-28 2006-01-19 Alza Corporation A drug/polymer complex, preferably ciprofloxacin/hpmc, its method of manufacturing using lyophilization and its use in an osmotic device
US7772182B2 (en) * 2004-08-05 2010-08-10 Alza Corporation Stable suspension formulations of erythropoietin receptor agonists
AU2006275718B8 (en) * 2005-07-28 2012-11-01 Takeda Pharmaceutical Company Limited Pharmaceutical formulations/composition of guanfacine suitable for single dose form adminstration daily
US20070098796A1 (en) 2005-10-31 2007-05-03 Rekhi Gurvinder S Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochrloride
US20070098791A1 (en) * 2005-10-31 2007-05-03 Rekhi Gurvinder S Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride
US8795721B2 (en) * 2006-12-18 2014-08-05 Eatlittle Inc. Device for delivery of a substance
ES2692437T3 (es) * 2007-08-13 2018-12-03 Abuse Deterrent Pharmaceutical Llc Fármacos resistentes al abuso, método de uso y método de preparación
US20090148532A1 (en) * 2007-12-06 2009-06-11 Venkatesh Gopi M Preparation of controlled release skeletal muscle relaxant dosage forms
AU2009223061B2 (en) 2008-03-11 2014-10-09 Depomed Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
US8372432B2 (en) 2008-03-11 2013-02-12 Depomed, Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
WO2010015840A1 (en) * 2008-08-08 2010-02-11 Cipla Limited Osmotic delivery device with modified release
EP2405754A4 (de) * 2009-03-09 2015-10-14 Relmada Therapeutics Inc Pharmazeutische buprenorphin-zusammensetzungen mit modifizierter freisetzung
CN101856339A (zh) * 2009-04-09 2010-10-13 广州柏赛罗药业有限公司 一种控释制剂及其制备方法
EP3132793A1 (de) 2009-12-02 2017-02-22 Adamas Pharmaceuticals, Inc. Amantadinzusammensetzungen und verfahren zur verwendung
US9198861B2 (en) 2009-12-22 2015-12-01 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
US8597681B2 (en) 2009-12-22 2013-12-03 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
GB2479213B (en) 2010-04-01 2013-07-10 Theravida Inc Pharmaceutical formulations for the treatment of overactive bladder
US8658631B1 (en) 2011-05-17 2014-02-25 Mallinckrodt Llc Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia
US8741885B1 (en) 2011-05-17 2014-06-03 Mallinckrodt Llc Gastric retentive extended release pharmaceutical compositions
US8858963B1 (en) 2011-05-17 2014-10-14 Mallinckrodt Llc Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
US20130220349A1 (en) * 2012-02-23 2013-08-29 Celanese Acetate Llc Deformable tablet with water triggered catalyst release
WO2014059309A1 (en) * 2012-10-11 2014-04-17 Theravida, Inc. Pharmaceutical formulations of pilocarpine
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
WO2014204933A1 (en) 2013-06-17 2014-12-24 Adamas Pharmaceuticals, Inc. Amantadine compositions and methods of use
CN108697688A (zh) 2016-01-20 2018-10-23 塞拉维达公司 用于治疗多汗症的方法和组合物
US11964048B2 (en) * 2020-12-18 2024-04-23 Amneal Complex Products Research Llc Sustained release compositions comprising liothyronine

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4058122A (en) * 1976-02-02 1977-11-15 Alza Corporation Osmotic system with laminated wall formed of different materials
US4008719A (en) * 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
US4014334A (en) * 1976-02-02 1977-03-29 Alza Corporation Laminated osmotic system for dispensing beneficial agent
US4063064A (en) * 1976-02-23 1977-12-13 Coherent Radiation Apparatus for tracking moving workpiece by a laser beam
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4285987A (en) * 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US5190765A (en) * 1991-06-27 1993-03-02 Alza Corporation Therapy delayed
US5160744A (en) * 1991-06-27 1992-11-03 Alza Corporation Verapmil therapy
US5869078A (en) * 1996-04-25 1999-02-09 Medtronic Inc. Implantable variable permeability drug infusion techniques
US6245357B1 (en) * 1998-03-06 2001-06-12 Alza Corporation Extended release dosage form
IL142807A0 (en) * 1998-11-02 2002-03-10 Alza Corp Controlled delivery of active agents

Also Published As

Publication number Publication date
CA2481236A1 (en) 2003-10-09
US20070184112A1 (en) 2007-08-09
AU2003224794A8 (en) 2003-10-13
US20030185888A1 (en) 2003-10-02
WO2003082207A2 (en) 2003-10-09
AU2003224794A1 (en) 2003-10-13
DE60322371D1 (de) 2008-09-04
JP2005521706A (ja) 2005-07-21
WO2003082207A3 (en) 2004-05-13
EP1499289B1 (de) 2008-07-23
EP1499289A2 (de) 2005-01-26

Similar Documents

Publication Publication Date Title
ATE401860T1 (de) Volumensparende arzneiform zur kontrollierten freisetzung
AR048185A1 (es) Sistema de entrega de farmacos constituido por uno o mas compartimentos, que comprende un compuesto progestagenico disuelto en un copolimero de polietileno acetato de vinilo termoplastico
ES2557988T3 (es) Método para tratar enfermedades de próstata basado en el suministro local de principios activos
NL2000281A1 (nl) Vaste farmaceutische samenstellingen die pregabaline bevatten.
WO2005097064A3 (en) Taste-masked drugs in rupturing multiparticulates
AR046290A1 (es) Agente terapeutico para el mesotelioma
AR053541A1 (es) Combinacion de xolair con agente inmunosupresor
CL2010000188A1 (es) Metodo para el tratamiento de una infeccion en un sujeto que comprende la administracion de 9-[(2,2-dimetil-propilamino)-metil]-minociclina o de una sal de la misma; composicion farmaceutica que comprende dicho compuesto; y su uso.
ATE381926T2 (de) Vitaminzusammenstellung mit verzögerter freigabe
IS6102A (is) Fljótleysanleg skammtaform sem innihalda gelatín úr fiski
EA200400966A1 (ru) Новые лекарственные формы замещенного бензимидазола и способ их применения
RU2004134728A (ru) Дозированные формы и композиции для осмотической доставки различных дозировок оксикодона
BRPI0409652A (pt) tablete, embalagem farmacêutica, método de tratamento de doenças, e, método de preparação de um tablete
ATE374601T1 (de) Multipartikuläre arzneiform, enthaltend mucoadhaesiv formulierte peptid- oder protein- wirkstoffe, sowie ein verfahren zur herstellung der arzneiform
DE60205749D1 (de) Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe
AR072075A2 (es) Un metodo para producir un lente antimicrobiano que comprende una sal metalica
WO2006030402A3 (en) Dual compartment osmotic delivery device
AR061047A1 (es) Comprimido bicapa para la prevencion de los accidentes cardiovasculares, su uso, y metodo para la prevencion de accidentes cardiovasculares
BRPI0513295A (pt) sistema de distribuição e método para controlar a liberação de pelo menos um agente terapeuticamente ativo a partir do mesmo
WO2005123134A3 (en) A controlled release delivery system for metformin
AR034517A1 (es) Formulacion farmaceutica
PE20080400A1 (es) Composicion farmaceutica para la anticoncepcion y para reducir el riesgo de malformaciones congenitas
SE0200895D0 (sv) New pharmaceutical composition
AR065342A1 (es) Composiciones farmaceuticas que contienen fumarato de quetiapina
ATE380545T1 (de) Pharmazeutische zubereitung mit verzögerter freisetzung zur oralen wirkstoffverabreichung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties